[Adjuvant therapy with pseudomonas immunoglobulin in artificially ventilated patients at a surgical intensive care unit].
Preoperative hospitalism and postoperative respiratory therapy together with antibiotical prophylaxis are risk factors for pulmonary infection due to Pseudomonas aeruginosa. Psomaglobin, a new Pseudomonas hyperimmune globulin, was given to 25 postoperative or posttraumatic patients during a prospective randomized study as an additional therapy for severe Pseudomonas infection. Respiratory therapy and therefore residence in the ICU were markedly shorter in the therapy (n = 25) than in the control group (n = 20).